Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 25, 2017

DrugPatentWatch Database Preview

Rizatriptan benzoate - Generic Drug Details

« Back to Dashboard

What are the generic sources for rizatriptan benzoate and what is the scope of rizatriptan benzoate freedom to operate?

Rizatriptan benzoate
is the generic ingredient in three branded drugs marketed by Glenmark Generics, Panacea Biotec Ltd, Cipla Ltd, Sandoz, Jubilant Generics, Unichem Labs Ltd, Invagen Pharms, Apotex Inc, Macleods Pharms Ltd, Eci Pharms Llc, Aurobindo Pharma Ltd, Teva Pharms, Merck, Alkem Labs Ltd, Mylan Pharms Inc, Natco Pharma Ltd, and Emcure Pharms Ltd, and is included in twenty-seven NDAs. There is one patent protecting this compound and two Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for rizatriptan benzoate. Twenty-eight suppliers are listed for this compound.

Summary for Generic Name: rizatriptan benzoate

Tradenames:3
Patents:1
Applicants:17
NDAs:27
Drug Master File Entries: see list22
Suppliers / Packagers: see list28
Bulk Api Vendors: see list61
Clinical Trials: see list18
Patent Applications: see list775
Therapeutic Class:Antimigraine Agents
Drug Prices:see low prices
DailyMed Link:rizatriptan benzoate at DailyMed

Pharmacology for Ingredient: rizatriptan benzoate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unichem Labs Ltd
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL207836-001Mar 7, 2017ABRXNoNo► Subscribe► Subscribe
Cipla Ltd
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL077526-001Mar 26, 2013ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL203062-001Jul 1, 2013ABRXNoNo► Subscribe► Subscribe
Glenmark Generics
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET;ORAL201967-002Dec 31, 2012ABRXNoNo► Subscribe► Subscribe
Apotex Inc
RIZATRIPTAN BENZOATE
rizatriptan benzoate
TABLET, ORALLY DISINTEGRATING;ORAL202477-002Jul 1, 2013ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Identify first generic entrants

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot